Volume : 10, Issue : 12, December – 2023
Title:
RANDOMIZED CONTROLLED TRAIL INVESTIGATING THE IMPACT OF KETOGENIC AND ADVANCED GLYCATION END PRODUCTS DIET ON METABOLIC HEALTH IN POLYCYSTIC OVARY SYNDROME
Authors :
Dr. S. Swarnalatha, R.Rajesh*, Deepika , S.Priyanka, R.Ramya
Abstract :
The aim of the study to evaluate compare the effect of ketogenic and Advanced glycation end product (AGE)on metabolic health insulin sensitivity and hormones balance in individuals with PCOS. PCOS is most common endocrine disorder PCOS linked to metabolic dysfunction in which increase type II diabetes, weight gain, decrease in insulin resistance reduced response to insulin by bodies cells this investigation aim to investigate possibility of food treatment AGE decrease intake of substance linked to increase oxidative stress and inflammation.The clinical trials study was conducted at Deepam hospital, perugalathur at Chennai on 100 patients with PCOS.Patients are classified randomly into two groups, Group A 50 patients -ketogenic diet group, Group B 50 patients -AGE diet both group recieved nutritional counseling and support above studies -30% PCOS individuals as increase ALT level and 42%-non alcoholic, fatty liver failure.In comparision to women without PCOS – half of women with PCOS where more likely to over weight /obese ketone bodies -decrease appetite and low calories intake.This pilot study demonstrated adhering low carb ketogenic diet improved symptoms and body weight,LH /FSH ratio fasting serum insulin .To contribute valuable insights into effect of KD and AGE diets and metabolic health individuals with PCOS.
Keywords: Ketogenic, Advanced glycation end product(AGE), PCOS, ALT, LH, FSH, Oxidative stress, Clinical trials
Cite This Article:
Please cite this article in press R.Rajesh et al., Randomized Controlled Trail Investigating The Impact Of Ketogenic And Advanced Glycation End Products Diet On Metabolic Health In Polycystic Ovary Syndrome, Indo Am. J. P. Sci, 2023; 10 (12).
Number of Downloads : 10
References:
1. Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet‐derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Annals of the New York Academy of Sciences. 2005 Jun;1043(1):461-6.
2. Mavropoulos JC, Yancy WS, Hepburn J, Westman EC. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutrition & metabolism. 2005 Dec;2(1):1-5.
3. Barrea L, Verde L, Camajani E, Cernea S, Frias-Toral E, Lamabadusuriya D, Ceriani F, Savastano S, Colao A, Muscogiuri G. Ketogenic diet as medical prescription in women with polycystic ovary syndrome (PCOS). Current Nutrition Reports. 2023 Mar;12(1):56-64.
4. Paoli A, Mancin L, Giacona MC, Bianco A, Caprio M. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. Journal of translational medicine. 2020 Dec;18(1):1-1.
5. Muscogiuri G, Palomba S, Laganà AS, Orio F. Current insights into inositol isoforms, Mediterranean and ketogenic diets for polycystic ovary syndrome: from bench to bedside. Current Pharmaceutical Design. 2016 Oct 1;22(36):5554-7.
6. Alwahab UA, Pantalone KM, Burguera B. A ketogenic diet may restore fertility in women with polycystic ovary syndrome: a case series. AACE Clinical Case Reports. 2018 Sep 1;4(5):e427-31.
7. Li J, Bai WP, Jiang B, Bai LR, Gu B, Yan SX, Li FY, Huang B. Ketogenic diet in women with polycystic ovary syndrome and liver dysfunction who are obese: A randomized, open‐label, parallel‐group, controlled pilot trial. Journal of Obstetrics and Gynaecology Research. 2021 Mar;47(3):1145-52.
8. Cincione RI, Losavio F, Ciolli F, Valenzano A, Cibelli G, Messina G, Polito R. Effects of mixed of a ketogenic diet in overweight and obese women with polycystic ovary syndrome. International journal of environmental research and public health. 2021 Nov 27;18(23):12490.
9. Masood I, Noreen S, Raza K, Khalid W, Rahim MA, Mohamedahmed KA. Effect of ketogenic diet and hypocaloric Mediterranean diet on metabolic and endocrine parameter in women suffering from Polycystic Ovary Syndrome. International Journal of Food Properties. 2023 Dec 15;26(2):3187-96.
10. Emami N, Alizadeh A, Maleki-Hajiagha A, Dizavi A, Vesali S, Moini A. Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome. Journal of Ovarian Research. 2023 Jun 30;16(1):127.
11. Azhary JM, Harada M, Kunitomi C, Kusamoto A, Takahashi N, Nose E, Oi N, Wada-Hiraike O, Urata Y, Hirata T, Hirota Y. Androgens increase accumulation of advanced glycation end products in granulosa cells by activating ER stress in PCOS. Endocrinology. 2020 Feb;161(2):bqaa015.
12. Lin PH, Chang CC, Wu KH, Shih CK, Chiang W, Chen HY, Shih YH, Wang KL, Hong YH, Shieh TM, Hsia SM. Dietary glycotoxins, advanced glycation end products, inhibit cell proliferation and progesterone secretion in ovarian granulosa cells and mimic PCOS-like symptoms. Biomolecules. 2019 Jul 31;9(8):327.
13. Gill V, Kumar V, Singh K, Kumar A, Kim JJ. Advanced glycation end products (AGEs) may be a striking link between modern diet and health. Biomolecules. 2019 Dec 17;9(12):888
14. Zhu JL, Cai YQ, Long SL, Chen Z, Mo ZC. The role of advanced glycation end products in human infertility. Life Sciences. 2020 Aug 15;255:117830.